Privilege not waived by DLA Piper phone call over Circadin patent

Article 2018-07-27 11:03 pm By Christine Caulfield | Melbourne

Please login to bookmark

Two generic drug makers have lost their bid for confidential documents related to Neurim Pharmaceuticals’ patents covering sleep drug Circadin, with a court ruling legal professional privilege was waived in a phone conversation between a DLA Piper lawyer and the company’s founder.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au